Huan Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huan Yang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Cece Yin
State Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
1 shared publication - Changyong Zhou
Integrative Science Center of Germplasm Creation in Western China (Chongqing) Science City, Citrus Research Institute, Southwest University, Chongqing, China/National Citrus Engineering Research Center, Citrus Research Institute, Southwest University, China
1 shared publication Chengrong Zhu
State Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
1 shared publication- Daniel J. Kliebenstein
Department of Plant Sciences, University of California , Davis, CA 95616
1 shared publication - Haixi Sun
BGI Research Beijing China
1 shared publication - Han Xiao
CAS Center for Excellence in Biotic Interactions, University of Chinese Academy of Sciences, Beijing, China
1 shared publication
Latest Publications
- Top Cited Papers
- 11 April 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6743) , 191-198
Targeted MYC2 stabilization confers citrus Huanglongbing resistance
Huanglongbing (HLB) is a devastating citrus disease. In this work, we report an HLB resistance regulatory circuit in Citrus composed of an E3 ubiquitin ligase, PUB21, and its substrate, the MYC2 transcription factor, which regulates jasmonate-mediated defense responses. A helitron insertion in the PUB21 promoter introduced multiple MYC2-binding cis-elements to create a regulatory circuit linking the PUB21 activity with MYC2 degradation. Ectopic expression of a natural dominant-negative PUB21 paralog discovered in distant Citrus relatives stabilized MYC2 and conferred resistance to HLB. Antiproteolysis peptides (APPs), identified by artificial intelligence, stabilized MYC2 by binding and inhibiting PUB21 activity. A 14–amino acid peptide, APP3-14, molecularly controlled HLB in greenhouse and field trials. This approach represents a strategy to combat uncultivable pathogens through targeted disease resistance protein stabilization.
- 11 April 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6743) , 191-198
Top Cited PapersTargeted MYC2 stabilization confers citrus Huanglongbing resistance
Huanglongbing (HLB) is a devastating citrus disease. In this work, we report an HLB resistance regulatory circuit in Citrus composed of an E3 ubiquitin ligase, PUB21, and its substrate, the MYC2 transcription factor, which regulates jasmonate-mediated defense responses. A helitron insertion in the PUB21 promoter introduced multiple MYC2-binding cis-elements to create a regulatory circuit linking the PUB21 activity with MYC2 degradation. Ectopic expression of a natural dominant-negative PUB21 paralog discovered in distant Citrus relatives stabilized MYC2 and conferred resistance to HLB. Antiproteolysis peptides (APPs), identified by artificial intelligence, stabilized MYC2 by binding and inhibiting PUB21 activity. A 14–amino acid peptide, APP3-14, molecularly controlled HLB in greenhouse and field trials. This approach represents a strategy to combat uncultivable pathogens through targeted disease resistance protein stabilization.